388 related articles for article (PubMed ID: 29948348)
1. Anti-annexin A5 antibodies and 25-hydroxy-cholecalciferol in female patients with primary antiphospholipid syndrome.
Bećarević M; Sarić M; Stojanovich L; Mirković D; Dopsaj V; Ignjatović S
Clin Rheumatol; 2018 Dec; 37(12):3359-3364. PubMed ID: 29948348
[TBL] [Abstract][Full Text] [Related]
2. The IgM isotype of anti-annexin A5 antibodies and multiple positivity of conventional antiphospholipid antibodies: increasing the number of clinical manifestations of primary antiphospholipid syndrome.
Bećarević M; Stojanović L; Ignjatović S; Dopsaj V
Clin Rheumatol; 2016 May; 35(5):1361-5. PubMed ID: 26971791
[TBL] [Abstract][Full Text] [Related]
3. The IgG and IgM isotypes of anti-annexin A5 antibodies: relevance for primary antiphospholipid syndrome.
Bećarević M
J Thromb Thrombolysis; 2016 Nov; 42(4):552-7. PubMed ID: 27307251
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the clinical relevance of anti-annexin-A5 antibodies in Chinese patients with antiphospholipid syndrome.
Zhang S; Wu Z; Li J; Wen X; Li L; Zhang W; Zhao J; Zhang F; Li Y
Clin Rheumatol; 2017 Feb; 36(2):407-412. PubMed ID: 28000012
[TBL] [Abstract][Full Text] [Related]
6. Double positivity of the IgG isotype of both anticardiolipin and anti-β2gpI antibodies is associated with the highest number of vascular impairment parameters in patients with primary antiphospholipid syndrome: preliminary data.
Bećarević M; Mirković D; Ignjatović S
Clin Rheumatol; 2016 Dec; 35(12):2947-2954. PubMed ID: 27743141
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid syndrome: critical analysis of the diagnostic path.
Pengo V; Banzato A; Bison E; Denas G; Padayattil Jose S; Ruffatti A
Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid antibodies in patients with COVID-19: A relevant observation?
Devreese KMJ; Linskens EA; Benoit D; Peperstraete H
J Thromb Haemost; 2020 Sep; 18(9):2191-2201. PubMed ID: 32619328
[TBL] [Abstract][Full Text] [Related]
9. Low prevalence of antiannexin A5 antibodies in unprovoked venous thrombosis.
Ho WK; Rigano J
Int J Lab Hematol; 2021 Oct; 43(5):1225-1228. PubMed ID: 33586909
[TBL] [Abstract][Full Text] [Related]
10. Reduction of annexin A5 anticoagulant ratio identifies antiphospholipid antibody-positive patients with adverse clinical outcomes.
Wolgast LR; Arslan AA; Wu XX; Beyda JN; Pengo V; Rand JH
J Thromb Haemost; 2017 Jul; 15(7):1412-1421. PubMed ID: 28393472
[TBL] [Abstract][Full Text] [Related]
11. Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?
Chayoua W; Yin DM; Kelchtermans H; Moore GW; Gris JC; Musiał J; Zuily S; Ten Cate H; de Laat B; Devreese KMJ
Thromb Haemost; 2020 Nov; 120(11):1557-1568. PubMed ID: 32696448
[TBL] [Abstract][Full Text] [Related]
12. Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome.
Anunciación-Llunell A; Muñoz C; Roggenbuck D; Frasca S; Pardos-Gea J; Esteve-Valverde E; Alijotas-Reig J; Miró-Mur F
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361608
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid and antioangiogenic activity in females with recurrent miscarriage and antiphospholipid syndrome.
Pelusa HF; Pezzarini E; Basiglio CL; Musuruana J; Bearzotti M; Svetaz MJ; Daniele SM; Bottai H; Arriaga SM
Ann Clin Biochem; 2017 Sep; 54(5):577-583. PubMed ID: 27638930
[TBL] [Abstract][Full Text] [Related]
14. Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications.
Nojima J; Kuratsune H; Suehisa E; Futsukaichi Y; Yamanishi H; Machii T; Iwatani Y; Kanakura Y
Clin Chem; 2001 Jun; 47(6):1008-15. PubMed ID: 11375285
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody explosion in antiphospholipid syndrome.
Shoenfeld Y; Twig G; Katz U; Sherer Y
J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
[TBL] [Abstract][Full Text] [Related]
16. Pandemic influenza immunization in primary antiphospholipid syndrome (PAPS): a trigger to thrombosis and autoantibody production?
de Medeiros DM; Silva CA; Bueno C; Ribeiro AC; Viana Vdos S; Carvalho JF; Bonfa E
Lupus; 2014 Nov; 23(13):1412-6. PubMed ID: 24961747
[TBL] [Abstract][Full Text] [Related]
17. Annexin-A5 resistance and non-criteria antibodies for the diagnosis of seronegative antiphospholipid syndrome.
Ferreira TG; Delhommeau F; Johanet C; Gerotziafas G; Bornes M; Cohen J; Kayem G; Fain O; Planche V; Mékinian A
Clin Rheumatol; 2020 Apr; 39(4):1167-1171. PubMed ID: 31925628
[TBL] [Abstract][Full Text] [Related]
18. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
[TBL] [Abstract][Full Text] [Related]
19. The clinical relevance of different antiphospholipid antibody profiles in pediatric rheumatology patients.
Pandya J; Onel K; Erkan D
Pediatr Rheumatol Online J; 2024 Apr; 22(1):46. PubMed ID: 38671480
[TBL] [Abstract][Full Text] [Related]
20. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.
Forastiero R
Lupus; 2014 Oct; 23(12):1252-4. PubMed ID: 25228718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
